                               SEQUENCE LISTING

<110> ASKLEPIOS BIOPHARMACEUTICAL, INC.
 
<120> METHOD FOR PURIFYING RECOMBINANT VIRAL PARTICLES

<130> 046192-098780WOPT

<140> PCT/US2022/013279
<141> 2022-01-21

<150> 63/282,001
<151> 2021-11-22

<150> 63/222,087
<151> 2021-07-15

<150> 63/139,997
<151> 2021-01-21

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
ggaaccccta gtgatggagt t                                                 21


<210> 2
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
cggcctcagt gagcga                                                       16


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 3
cactccctct ctgcgcgctc g                                                 21


